Plato Investment Management’s DexCom DXCM Stock Holding History

Plato Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$734K	Sell	11,681 -2,683	-19%	-$187K	0.05%	308
2025 Q4	$958K	Hold	14,364	–	–	0.06%	268
2025 Q3	$959K	Buy	14,364 +44	+0.3%	+$3.48K	0.07%	267
2025 Q2	$1.25M	Buy	14,320 +3	+0%	+$235	0.09%	222
2025 Q1	$988K	Sell	14,317 -1,176	-8%	-$96K	0.08%	246
2024 Q4	$1.21M	Buy	15,493 +7,890	+104%	+$584K	0.09%	233
2024 Q3	$509K	Sell	7,603 -5,802	-43%	-$476K	0.04%	315
2024 Q2	$1.52M	Sell	13,405 -358	-3%	-$45.3K	0.14%	156
2024 Q1	$1.91M	Buy	13,763 +11,346	+469%	+$1.43M	0.2%	125
2023 Q4	$300K	Buy	+2,417	New	+$247K	0.37%	70

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Plato Investment Management's DXCM Position: Q1 2026 in Review

Plato Investment Management reduced its DexCom (DXCM) stake by 19% in Q1 2026, selling an estimated $187K and leaving 11,681 shares worth $734K. The position accounts for 0.05% of the portfolio, ranked #308.

Plato Investment Management first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.91M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Plato Investment Management held 11,681 shares of DexCom worth $734K as of Q1 2026.
Plato Investment Management sold 2,683 DexCom shares in Q1 2026, an estimated $187K.
DexCom made up 0.05% of Plato Investment Management's portfolio in Q1 2026, its #308 holding.
Plato Investment Management first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
Plato Investment Management's DexCom position peaked at $1.91M in Q1 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.